Search Within

Daphna Y Gelblum

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
  3. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (15)
  2. Radiation Oncology, Department of (15)
  3. Department of Medicine (14)
  4. Solid Tumor Oncology Division (14)
  5. Radiology, Department of (12)
  6. Surgery (10)

More Groups

People
  1. Nancy Lee (9)
  2. Andreas Rimner (8)
  3. David Pfister (7)
  4. Eric Sherman (7)
  5. Annemarie Shepherd (6)
  6. Daniel Gomez (6)

More People

Years
  1. 2024 (5)
  2. 2023 (2)
  3. 2022 (2)
  4. 2017 (3)
  5. 2016 (1)
  6. 2014 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Journal of Clinical Oncology (4)
  3. Radiotherapy and Oncology (2)
  4. Annals of Oncology (1)
  5. Head & Neck (1)
  6. JTO Clinical and Research Reports (1)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. American Society of Clinical Oncology (4)
  3. Elsevier BV (1)
  4. Elsevier Science, Inc. (1)
  5. John Wiley & Sons, Inc. (1)
  6. Oxford University Press (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A personalized approach using hypoxia resolution to guide curative-intent radiation therapy dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers treated with concurrent chemoradiation therapy
    Meeting Abstract

    Riaz, N.; Sherman, E.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J. O.; Singh, B.; Morris, L.; Wong, R. J.; Tsai, C. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • FDG-PET maximum standardized uptake value and histological subtype predict high risk for recurrence in early-stage lung adenocarcinoma treated with stereotactic body radiation therapy
    Meeting Abstract

    Pitter, K.; Leeman, J. E.; Kohutek, Z. A.; Gelb, E.; Montecalvo, J.; Travis, W.; Adusumilli, P.; Yorke, E. D.; Gelblum, D.; Wu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save